Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 8 Neoplasms 4 Multiple Myeloma 3 Radiation Injuries 2 Multiple Chronic Conditions 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Esophageal Neoplasms 2 Cognitive Dysfunction 2 Brain Neoplasms 2 Substance-Related Disorders 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Pain 1 Osteosarcoma 1 Neoplasms, Second Primary 1 Neoplasms, Plasma Cell 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Mobility Limitation 1 Melanoma 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia 1 Kidney Neoplasms 1 Hyperthermia 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Surveys and Questionnaires 15 Acupuncture Therapy 15 Fentanyl 14 Morphine 13 Acetaminophen 13 Analgesia 12 Lidocaine 11 Ketamine 11 Bupivacaine 11 Methadone 10 Therapeutics 9 Ropivacaine 9 Psychiatric Rehabilitation 9 Oxycodone 9 Hydromorphone 7 Saline Solution 6 Radiotherapy 6 Music Therapy 6 Early Intervention, Educational 6 Zoledronic Acid 5 Yoga 5 Water 5 Methods 5 Control Groups 5 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Physical Therapy Modalities 4 Massage 4 Ketorolac 4 Exercise 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pain × Patient Reported Outcome Measures × Clear all

NCT05684939 2023-06-13

CAPS

University Hospital, Clermont-Ferrand

Neoplasms, Pain, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡